-
EP1553925
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1553925
| EP1553925 - MODIFIED RELEASE ORAL DOSAGE FORM [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.01.2014 Database last updated on 03.09.2024 | Most recent event Tooltip | 03.01.2014 | Application deemed to be withdrawn | published on 05.02.2014 [2014/06] | Applicant(s) | For all designated states GlaxoSmithKline LLC One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 / US | [N/P] |
| Former [2010/09] | For all designated states GlaxoSmithKline LLC One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 / US | ||
| Former [2005/29] | For all designated states SmithKline Beecham Corporation One Franklin Plaza Philadelphia, PA 19103 / US | Inventor(s) | 01 /
GRAFF, Allan, H. 1500 Littleton Road Parsippany, NJ 07054 / US | 02 /
PLATCOW, Stuart, J. 1500 Littleton Road Parsippany, NJ 07054 / US | [2005/29] | Representative(s) | Morris, Miriam Elizabeth GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2005/29] | Morris, Miriam Elizabeth GlaxoSmithKline Corporate Intellectual Property 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 03749740.1 | 16.09.2003 | [2005/29] | WO2003US29277 | Priority number, date | US20020244782 | 16.09.2002 Original published format: US 244782 | [2005/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004024124 | Date: | 25.03.2004 | Language: | EN | [2004/13] | Type: | A1 Application with search report | No.: | EP1553925 | Date: | 20.07.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.03.2004 takes the place of the publication of the European patent application. | [2005/29] | Search report(s) | International search report - published on: | US | 25.03.2004 | (Supplementary) European search report - dispatched on: | EP | 07.08.2012 | Classification | IPC: | A61K9/14, A61K9/20, A61K9/00 | [2012/36] | CPC: |
A61K9/0056 (EP,US);
A61K9/2018 (EP,US);
A61K9/2059 (EP,US);
A61P25/34 (EP)
|
| Former IPC [2005/29] | A61K9/14 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/29] | Extension states | AL | Not yet paid | LT | 12.04.2005 | LV | 12.04.2005 | MK | Not yet paid | Title | German: | ORALE DOSIERUNGSFORM MIT MODIFIZIERTER FREISETZUNG | [2005/29] | English: | MODIFIED RELEASE ORAL DOSAGE FORM | [2005/29] | French: | FORME POSOLOGIQUE ORALE A LIBERATION MODIFIEE | [2005/29] | Entry into regional phase | 12.04.2005 | National basic fee paid | 12.04.2005 | Search fee paid | 12.04.2005 | Designation fee(s) paid | 12.04.2005 | Examination fee paid | Examination procedure | 17.03.2004 | Request for preliminary examination filed International Preliminary Examining Authority: US | 12.04.2005 | Examination requested [2005/29] | 28.01.2013 | Despatch of a communication from the examining division (Time limit: M06) | 08.08.2013 | Application deemed to be withdrawn, date of legal effect [2014/06] | 30.09.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/06] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.01.2013 | Fees paid | Renewal fee | 05.09.2005 | Renewal fee patent year 03 | 08.09.2006 | Renewal fee patent year 04 | 05.09.2007 | Renewal fee patent year 05 | 05.09.2008 | Renewal fee patent year 06 | 04.09.2009 | Renewal fee patent year 07 | 07.09.2010 | Renewal fee patent year 08 | 08.09.2011 | Renewal fee patent year 09 | 26.09.2012 | Renewal fee patent year 10 | 09.09.2013 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]GB2049417 (MITRA A K) [X] 1-11,13-15,22-25,27 * claims 1-5 * * tables 7,8 *; | [X]GB2187642 (COLGATE PALMOLIVE CO) [X] 1-11,13-15,22-25,27 * example 11 *; | [X]WO9742941 (NOVARTIS CONSUMER HEALTH SA [CH], et al) [X] 1-11,13-18,22-33 * examples 1-5 * * claims 1-13 *; | [X]DE19815327 (SOLDAN HOLDING & BONBONSPEZIAL [DE]) [X] 1-15,19-25 * claims 1-9 *; | [X]DE20102817U (BOLDER ARZNEIMITTEL GMBH [DE]) [X] 1-11,13-15,22-25,27 * example 2 *; | [X]WO02062315 (PHARMACIA CORP [US], et al) [X] 1-11,13-18,22-33 * example 3 *; | [XP]WO02085334 (PF MEDICAMENT [FR], et al) [XP] 1-33 * claims 1-15 ** paragraph [0101] - paragraph [0120] * | International search | [A]US5048544 (MASCARELLI ROBERT [US], et al); | [A]US5721257 (BAKER RICHARD W [US], et al) |